TBX10: A Multi-Signaling-Pathway Protein with Potential as A Drug Target Or Biomarker

Target Name: TBX10

NCBI ID: G347853

TBX10

TBX10: A Multi-Signaling-Pathway Protein with Potential as A Drug Target Or Biomarker

TBX10 (TBX13) is a protein that is expressed in various tissues of the body, including the lungs, heart, kidneys, and intestines. It is a member of the T-cell signaling pathway, which is a critical pathway involved in the regulation of immune responses.

Research has shown that TBX10 plays a role in the regulation of immune cell function and has been implicated in a number of diseases, including cancer, autoimmune disorders, and neurodegenerative diseases. Its role in these processes has led to its potential as a drug target or biomarker.

One of the key features of TBX10 is its ability to interact with several different signaling pathways, including the T-cell signaling pathway, the microtubule dynamics pathway, and the PI3K/Akt signaling pathway. This makes it a potentially versatile target for drugs that can modulate these pathways.

In addition to its role in signaling pathways, TBX10 has also been shown to play a role in the regulation of cellular processes that are important for maintaining tissue homeostasis. This includes the regulation of cell adhesion, migration, and the formation of tissues such as blood vessels and airways.

Overall, TBX10 is a protein that has significant potential as a drug target or biomarker due to its involvement in multiple signaling pathways and its role in maintaining tissue homeostasis. Further research is needed to fully understand its functions and potential uses in medicine.

Protein Name: T-box Transcription Factor 10

Functions: Probable transcriptional regulator involved in developmental processes

The "TBX10 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TBX10 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets